Alva B. Weir

1.8k total citations
43 papers, 941 citations indexed

About

Alva B. Weir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Alva B. Weir has authored 43 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Alva B. Weir's work include Head and Neck Cancer Studies (7 papers), Hepatitis C virus research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Alva B. Weir is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Hepatitis C virus research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Alva B. Weir collaborates with scholars based in United States, Australia and Hungary. Alva B. Weir's co-authors include Frank S. H. Wong, R. Ferguson, Pamela Flick, Thomas Murry, K. Thomas Robbins, Catherine Hanchett, William F. Hartsell, Jesse E. Edwards, Robert L. Palmer and Stephen B. Howell and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alva B. Weir

40 papers receiving 904 citations

Peers

Alva B. Weir
Mathew Simcock Switzerland
Zahra Maleki United States
Reggie Duerst United States
Mark Stevens Australia
John R. Craig United States
Andrew Gross United States
Cindy McGrath United States
Mathew Simcock Switzerland
Alva B. Weir
Citations per year, relative to Alva B. Weir Alva B. Weir (= 1×) peers Mathew Simcock

Countries citing papers authored by Alva B. Weir

Since Specialization
Citations

This map shows the geographic impact of Alva B. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alva B. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alva B. Weir more than expected).

Fields of papers citing papers by Alva B. Weir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alva B. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alva B. Weir. The network helps show where Alva B. Weir may publish in the future.

Co-authorship network of co-authors of Alva B. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of Alva B. Weir. A scholar is included among the top collaborators of Alva B. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alva B. Weir. Alva B. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weir, Alva B., et al.. (2025). Black Veterans’ Insight on Racial Disparities in Military Administrative Separations. Journal of Veterans Studies. 11(1). 1–15. 1 indexed citations
2.
Xu, Zeyan, Alva B. Weir, Hong-Yu Zhou, et al.. (2024). An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer. Nature Communications. 15(1). 9613–9613. 24 indexed citations
3.
Weir, Alva B.. (2021). Antiviral Therapy Improves Hepatocellular Cancer Survival. Federal Practitioner. 38(38 (Suppl 3)). e58–e63.
4.
Otieno, Steve, et al.. (2020). Rapid Response in a Patient with Relapsed/Refractory Multiple Myeloma Treated with BRAF/MEK Inhibitors. SHILAP Revista de lepidopterología. 2020. 1–4. 3 indexed citations
5.
Otieno, Steve, et al.. (2020). CIN or not: An approach to the evaluation and management of chronic idiopathic neutrophilia. Blood Reviews. 46. 100739–100739. 4 indexed citations
6.
Shih, Kent C., Sajeel Chowdhary, Alva B. Weir, et al.. (2016). A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma. Journal of Neuro-Oncology. 129(2). 281–288. 88 indexed citations
7.
Johnson, Benny, Maged Khalil, Joseph Blansfield, et al.. (2016). Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 6(7). E113–E117. 5 indexed citations
8.
Sachdev, Jasgit C., et al.. (2014). A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 32(15_suppl). 4098–4098. 5 indexed citations
9.
Rodgers, George M., Jeffrey A. Gilreath, Morey A. Blinder, et al.. (2014). NCCN Guidelines Version 3.2014 Panel Members Cancer- and Chemotherapy-Induced Anemia. 3 indexed citations
10.
Sheehan, Vivien, Alva B. Weir, & Bradford Waters. (2013). Hepatitis C and neutropenia. Current Opinion in Hematology. 21(1). 58–63. 9 indexed citations
11.
Lewis, James E., et al.. (2013). Evaluation of a Method to Improve the Consent Process: Improved Data Retention with Stagnant Comprehension. Journal of Cancer Education. 28(1). 38–42. 3 indexed citations
12.
Rodgers, George M., Pamela S. Becker, Morey A. Blinder, et al.. (2012). Cancer- and Chemotherapy-Induced Anemia. Journal of the National Comprehensive Cancer Network. 10(5). 628–653. 171 indexed citations
13.
Ganti, Apar Kishor, et al.. (2012). Treatment of Non–Small Cell Lung Cancer in the Older Patient. Journal of the National Comprehensive Cancer Network. 10(2). 230–239. 18 indexed citations
14.
Weir, Alva B., et al.. (2012). Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations. Journal of Geriatric Oncology. 3(3). 265–272. 1 indexed citations
15.
Robbins, K. Thomas, Frank S. H. Wong, William F. Hartsell, et al.. (2000). Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients. Head & Neck. 22(7). 687–693. 168 indexed citations
16.
Fontanesi, James, Frank S. H. Wong, Daniel Vicario, et al.. (1996). A Novel Organ Preservation Protocol for Advanced Carcinoma of the Larynx and Pharynx. Archives of Otolaryngology - Head and Neck Surgery. 122(8). 853–857. 70 indexed citations
17.
Fontanesi, James, W. Craig Clark, Alva B. Weir, et al.. (1993). Interstitial Iodine 125 and Concomitant Cisplatin Followed by Hyperfractionated External Beam Irradiation for Malignant Supratentorial Glioma. American Journal of Clinical Oncology. 16(5). 412–417. 3 indexed citations
18.
Weir, Alva B., et al.. (1987). Delayed Hemolytic Transfusion Reaction Caused by Anti‐LebH Antibody. Vox Sanguinis. 53(2). 105–107. 6 indexed citations
19.
Weir, Alva B.. (1980). Plasma Exchange in Idiopathic Thrombocytopenic Purpura. Archives of Internal Medicine. 140(8). 1101–1101. 13 indexed citations
20.
Edwards, Jesse E., et al.. (1958). CONGENITAL COMMUNICATION BETWEEN THE RIGHT CORONARY ARTERY AND THE RIGHT ATRIUM. Journal of Thoracic Surgery. 35(5). 662–673. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026